Gene: SYTL5
Official Full Name: synaptotagmin like 5provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the synaptotagmin-like (Slp) protein family, which contains a unique homology domain at the N-terminus, referred to as the Slp homology domain (SHD). The SHD functions as a binding site for Rab27A, which plays a role in protein transport. Expression of this gene is restricted to placenta and liver, suggesting that it might be involved in Rab27A-dependent membrane trafficking in specific tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22064 | SYTL5 Knockout cell line (HEK293) | Human | SYTL5 | 1:3~1:6 | Negative | Online Inquiry |
SYTL5 Gene Knockout Cell Lines are sophisticated cellular models created using targeted genome editing techniques to inactivate the SYTL5 gene, which plays a crucial role in intracellular transport processes. These cell lines are invaluable for studying the biological functions of SYTL5, including its involvement in vesicular trafficking, signal transduction, and cellular response mechanisms. By systematically removing the gene’s expression, researchers can observe phenotypic changes and elucidate the gene’s role in various physiological and pathological processes.
The key functional mechanism of these cell lines lies in the CRISPR-Cas9 gene editing technology employed to achieve specific disruption of the SYTL5 gene. This precision-based method ensures a complete knockout, allowing for the assessment of alterations in cellular behavior, protein interactions, and metabolic pathways associated with SYTL5 activities. Such studies are critical for understanding its implications in conditions like cancer, neurodegenerative diseases, and metabolic disorders.
In terms of scientific importance, SYTL5 Gene Knockout Cell Lines offer profound applications in both research and clinical settings. They are essential for drug discovery and development, enabling researchers to screen potential therapeutics that target specific pathways influenced by SYTL5. Furthermore, their utility in basic research enhances our understanding of gene function and regulation in cellular contexts, which is invaluable for advancing predictive and personalized medicine.
What sets our SYTL5 Gene Knockout Cell Lines apart from alternative models is their high specificity and reliability, ensuring minimal off-target effects, thus providing data that is not only reproducible but also translationally relevant. Additionally, our product is backed by comprehensive technical support and validated protocols, enhancing user-friendliness for both novice and experienced researchers.
For researchers and clinicians committed to exploring the molecular intricacies of cellular behavior, the SYTL5 Gene Knockout Cell Lines represent a transformative tool that integrates seamlessly into various research pipelines. Our expertise in developing precision biological products, combined with thorough quality assurance, makes us a trusted partner in advancing your scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.